Variable | LR | Â | RR | Â |
---|---|---|---|---|
 | HR (95% CI) | P | HR (95% CI) | P |
Age, y | Â | 0.001 | Â | <0.001 |
 >45 | 1.000 |  | 1.000 |  |
  ≤ 45 | 1.688 (1.232–2.313) |  | 2.061 (1.560–2.723) |  |
Tumor location | Â | <0.001 | Â | 0.001 |
 Other quadrants | 1.000 |  | 1.000 |  |
 Inner quadrant | 2.059 (1.488–2.851) |  | 1.684 (1.251–2.268) |  |
No. of axillary nodes dissected | Â | 0.428 | Â | 0.299 |
  ≥ 10 | 1.000 |  | 1.000 |  |
 <10 | 1.337 (0.652–2.741) |  | 1.407 (0.738–2.682) |  |
T Stage | Â | <0.001 | Â | <0.001 |
 T1–2 | 1.000 |  | 1.000 |  |
 T3–4 | 7.381 (4.097–13.296) |  | 3.585 (2.025–6.349) |  |
N Stage | Â | <0.001 | Â | <0.001 |
 N0 | 1.000 |  | 1.000 |  |
 N1 | 2.070 (1.455–2.944) |  | 3.215 (2.321–4.453) |  |
 N2 | 2.716 (1.241–5.947) |  | 5.169 (2.752–9.709) |  |
 N3 | 9.871 (5.223–18.656) |  | 12.636 (7.215–22.131) |  |
Tumor grade | Â | 0.144 | Â | 0.110 |
 1 | 1.000 |  | 1.000 |  |
 2 | 3.719 (0.913–15.147) |  | 1.433 (0.626–3.282) |  |
 3 | 4.109 (0.992–17.010) |  | 1.881 (0.807–4.384) |  |
Hormone receptor status | Â | 0.002 | Â | 0.007 |
 Positive | 1.000 |  | 1.000 |  |
 Negative | 1.741 (1.236–2.454) |  | 1.536 (1.123–2.102) |  |
Her2 status | Â | Â | Â | 0.535 |
 Negative |  |  | 1.000 |  |
 Positive |  |  | 1.105 (0.806–1.515) |  |
Chemotherapy | Â | 0.256 | Â | 0.247 |
 No | 1.000 |  | 1.000 |  |
 Yes | 1.374 (0.794–2.380) |  | 1.371 (0.804–2.337) |  |